0001179110-13-004098.txt : 20130305
0001179110-13-004098.hdr.sgml : 20130305
20130305100314
ACCESSION NUMBER: 0001179110-13-004098
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20130301
FILED AS OF DATE: 20130305
DATE AS OF CHANGE: 20130305
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: EYLENBOSCH HILDE
CENTRAL INDEX KEY: 0001272540
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-16789
FILM NUMBER: 13664121
MAIL ADDRESS:
STREET 1: 51 SAWYER ROAD
STREET 2: C/O INVERNESS MEDICAL INNOVATIONS INC
CITY: WALTHAM
STATE: MA
ZIP: 02453
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ALERE INC.
CENTRAL INDEX KEY: 0001145460
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 043565120
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 51 SAWYER ROAD
STREET 2: SUITE 200
CITY: WALTHAM
STATE: MA
ZIP: 02453
BUSINESS PHONE: 7816473900
MAIL ADDRESS:
STREET 1: 51 SAWYER ROAD
STREET 2: SUITE 200
CITY: WALTHAM
STATE: MA
ZIP: 02453
FORMER COMPANY:
FORMER CONFORMED NAME: INVERNESS MEDICAL INNOVATIONS INC
DATE OF NAME CHANGE: 20010720
4
1
edgar.xml
FORM 4 -
X0306
4
2013-03-01
0
0001145460
ALERE INC.
ALR
0001272540
EYLENBOSCH HILDE
51 SAWYER ROAD, SUITE 200
WALTHAM
02453
0
1
0
0
President, Alere International
Common Stock
2013-03-01
4
M
0
2500
16.20
A
32636
D
Common Stock
2013-03-01
4
S
0
2391
22.687
D
30245
D
Common Stock
43143
I
Spouse
Common Stock
3248
D
Employee Stock Option (Right to Buy)
16.20
2013-03-01
4
M
0
2500
D
2004-03-10
2013-03-10
Common Shares
2500
0
D
Reresents sell to cover exercise of expiring stock options.
The sales reported on this Form 4 were effected purusant to a Rule 10b5-1 trading plan adopted by the reporting person on November 12, 2012.
The price represents the average purchase price for 14 separate transactions reported on this line. The price of the transactions reported on this line range from $22.68 to $22.70. The reporting person hereby undertakes to provide upon request to the SEC,the issuer or any stockholder of the issuer the full informaiton regarding the number of shares and prices at which the transaction was effected.
This reporting person disclaims beneficial ownership of the reported securities.
These securities are jointly owned with the reporting person's spouse.
This derivative security does not have a price.
/s/ Jay McNamara, Attorney-in-Fact
2013-03-05